4.8 Article

Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota

期刊

ACS APPLIED MATERIALS & INTERFACES
卷 13, 期 39, 页码 46406-46420

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsami.1c14818

关键词

Alzheimer's disease; amyloid-beta; oxidative stress; neuroinflammation; gut microbiota imbalance; resveratrol-selenium-peptide nanocomposites

资金

  1. National Natural Science Foundation of China [21701068, 21967010]

向作者/读者索取更多资源

A Res-selenium-peptide nanocomposite was developed to improve cognitive dysfunction in AD model mice by reducing Aβ aggregation, inhibiting Aβ deposition, decreasing oxidative stress and inflammation, and alleviating gut microbiota disorder.
Alzheimer's disease (AD) is a neurodegenerative disease associated with amyloid-beta (A beta ) deposition, leading to neurotoxicity (oxidative stress and neuroinflammation) and gut microbiota imbalance. Resveratrol (Res) has neuroprotective properties, but its bioavailability in vivo is very low. Herein, we developed a small Resselenium-peptide nanocomposite to enable the application of Res for eliminating A beta aggregate-induced neurotoxicity and mitigating gut microbiota disorder in aluminum chloride (AlCl3) and D-galactose(D-gal)-induced AD model mice. Res functional selenium nanoparticles (Res@SeNPs) (8 +/- 0.34 nm) were prepared first, after which the surface of Res@SeNPs was decorated with a blood-brain barrier transport peptide (TGN peptide) to generate Res-selenium-peptide nanocomposites (TGN-Res@SeNPs) (14 +/- 0.12 nm). Oral administration of TGN-Res@SeNPs improves cognitive disorder through (1) interacting with AP and decreasing A beta aggregation, effectively inhibiting A beta deposition in the hippocampus; (2) decreasing A beta-induced reactive oxygen species (ROS) and increasing activity of antioxidation enzymes in PC12 cells and in vivo; (3) down-regulating A beta-induced neuroinflammation via the nuclear factor kappa B/mitogen-activated protein kinase/Akt signal pathway in BV-2 cells and in vivo; and (4) alleviating gut microbiota disorder, particularly with respect to oxidative stress and inflammatory-related bacteria such as Alistipes, Helicobacter, Rikenella, Desulfovibrio, and Faecalibaculum. Thus, we anticipate that Res-selenium-peptide nanocomposites will offer a new potential strategy for the treatment of AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nanoscience & Nanotechnology

Multifunctional Selenium Nanoparticles with Different Surface Modifications Ameliorate Neuroinflammation through the Gut Microbiota-NLRP3 Inflammasome-Brain Axis in APP/PS1 Mice

Licong Yang, Yanan Cui, Hanji Liang, Zhiwei Li, Na Wang, Yabin Wang, Guodong Zheng

Summary: Neuroinflammation in Alzheimer's disease can be effectively treated using selenium nanoparticles with different surface modifications. Specifically, Tg-CS/DMY@SeNPs, which are decorated with the blood brain barrier targeting peptide Tg, show improved anti-inflammatory effects and can cross the blood brain barrier to inhibit A beta aggregation. Furthermore, both Tg-CS/DMY@SeNPs and CS/DMY@SeNPs can repair the gut barrier and regulate the population of inflammatory-related gut microbiota.

ACS APPLIED MATERIALS & INTERFACES (2022)

Article Agriculture, Multidisciplinary

A Flower-like Brain Targeted Selenium Nanocluster Lowers the Chlorogenic Acid Dose for Ameliorating Cognitive Impairment in APP/PS1 Mice

Zhiwei Li, Guodong Zheng, Na Wang, Hanji Liang, Changjiang Li, Yabin Wang, Yanan Cui, Licong Yang

Summary: Beta aggregation-related neuroinflammation and brain glucose homeostasis imbalance are important factors in Alzheimer's disease. Chlorogenic acid (CGA) is a common dietary polyphenol with neuroprotective effects, however, its bioavailability is low. This study developed a new flowerlike selenium nanocluster (TGN-CGA@SeNCs) to enhance the bioavailability of CGA.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2023)

Article Agriculture, Multidisciplinary

A Flower-like Brain Targeted Selenium Nanocluster Lowers the Chlorogenic Acid Dose for Ameliorating Cognitive Impairment in APP/PS1 Mice

Zhiwei Li, Guodong Zheng, Na Wang, Hanji Liang, Changjiang Li, Yabin Wang, Yanan Cui, Licong Yang

Summary: Beta aggregation-related neuroinflammation and brain glucose homeostasis imbalance are important in Alzheimer's disease (AD). Chlorogenic acid (CGA) has neuroprotective effects, but its low bioavailability necessitates high in vivo application doses. To enhance CGA bioavailability, a brain-targeting peptide (TGN peptide) and CGA were used to prepare a new flowerlike selenium nanocluster (TGN-CGA@SeNCs). TGN-CGA@SeNCs significantly improved CGA solubility, stability, and function in ameliorating gut microbiota disorder, A beta aggregation, and brain glucose homeostasis, providing potential for preventing AD progression.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2023)

暂无数据